SPONSOR
Guangzhou Medical University
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Guangzhou Medical University is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Leptomeningeal Metastasis, Intrathecal Drug Delivery.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Guangzhou Medical University
How many clinical trials has Guangzhou Medical University sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Guangzhou Medical University, of which 1 are actively recruiting participants. These trials cover conditions including Leptomeningeal Metastasis, Intrathecal Drug Delivery. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Guangzhou Medical University research focus on?
Guangzhou Medical University clinical trials span Leptomeningeal Metastasis, Intrathecal Drug Delivery. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Guangzhou Medical University clinical trial?
To participate in a Guangzhou Medical University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Guangzhou Medical University trials with current recruitment status updated daily.
Clinical Trials by Guangzhou Medical University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology